Halting neuroblastoma metastasis by controlling integrin-mediated death

Tal Teitz, Dwayne G. Stupack, Jill M. Lahti

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Neuroblastoma, a common tumor of nervous system origin in young children, is usually detected only after the primary tumor has metastasized and the chances of its complete removal are low. Metastatic neuroblastoma cells commonly suppress expression of the gene encoding caspase-8. In a neuroblastoma murine model, expression of caspase-8 and integrin α3β1 was dramatically reduced during tumor development. Analysis of clinical biopsies supported the observation that expression of both genes is low in human patients with metastatic disease. These data suggest that loss of expression of both caspase-8 and unligated integrins contribute to the survival of tumor cells migrating from the primary tumor. Integrin receptors that are unable to find appropriate ligands can form a large molecular complex containing caspase-8, explaining why cells that have diminished expression of either of these two genes have a significant survival advantage in foreignmicroenvironments. Thus, upregulating expression of caspase-8 and integrins, or alternatively, antagonizing integrins within the primary tumor may be important therapeutically in halting neuroblastoma metastasis.

Original languageEnglish (US)
Pages (from-to)681-685
Number of pages5
JournalCell Cycle
Issue number7
StatePublished - Apr 1 2006
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Developmental Biology
  • Cell Biology


Dive into the research topics of 'Halting neuroblastoma metastasis by controlling integrin-mediated death'. Together they form a unique fingerprint.

Cite this